$22.91
0.723.24%
At Close: -
$22.91
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Akero Therapeutics: Insider buying and selling updated today.
Jul 02, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -3.936K | $21.67 | -$95.80K | SELL | -1.45% | 266.854K | Jun 28 - Jul 01 | View |
Jun 13, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -2.516K | $22.64 | -$56.96K | SELL | -0.92% | 270.79K | Jun 11 | View |
Jun 13, 2024 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -2.825K | $22.64 | -$63.96K | SELL | -3.64% | 74.867K | Jun 11 | View |
Jun 13, 2024 | Richard William White | CHIEF FINANCIAL OFFICER | -2.831K | $22.64 | -$64.09K | SELL | -5.70% | 46.799K | Jun 11 | View |
Jun 13, 2024 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -2.38K | $22.64 | -$53.89K | SELL | -1.30% | 180.178K | Jun 11 | View |
Jun 13, 2024 | Patrick Lamy | SENIOR VP, COMMERCIAL STRATEGY | -569 | $22.64 | -$12.88K | SELL | -2.97% | 18.562K | Jun 11 | View |
Jun 13, 2024 | Andrew Cheng | PRESIDENT AND CEO | -7.894K | $22.64 | -$178.73K | SELL | -1.34% | 581.553K | Jun 11 | View |
Jun 05, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -5K | $19.29 | -$96.44K | SELL | -1.80% | 273.306K | Jun 03 | View |
May 02, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -5K | $20.15 | -$100.75K | SELL | -1.76% | 278.306K | May 01 | View |
Apr 03, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -5K | $24.38 | -$121.91K | SELL | -1.73% | 283.306K | Apr 01 | View |
Mar 15, 2024 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -723 | $28.33 | -$20.48K | SELL | -0.92% | 77.692K | Mar 13 | View |
Mar 15, 2024 | Richard William White | CHIEF FINANCIAL OFFICER | -724 | $28.33 | -$20.51K | SELL | -1.44% | 49.63K | Mar 13 | View |
Mar 15, 2024 | Andrew Cheng | PRESIDENT AND CEO | -1.969K | $28.33 | -$55.78K | SELL | -0.33% | 589.447K | Mar 13 | View |
Mar 15, 2024 | Jonathan Young | CHIEF OPERATING OFFICER | -651 | $28.33 | -$18.44K | SELL | -0.23% | 288.306K | Mar 13 | View |
Mar 15, 2024 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -619 | $28.33 | -$17.54K | SELL | -0.34% | 182.558K | Mar 13 | View |
Mar 06, 2024 | Andrew Cheng | PRESIDENT AND CEO | 0 | $25.02 | -$1.18M | SELL-OPTIONS | 0.00% | 591.416K | Mar 04 | View |
Mar 06, 2024 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | 0 | $24.72 | -$444.60K | SELL-OPTIONS | 0.00% | 78.415K | Mar 04 | View |
Dec 29, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | 0 | $15.18 | -$95.50K | SELL-OPTIONS | 0.00% | 205.131K | Dec 27 | View |
Dec 18, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -597 | $20.76 | -$12.39K | SELL | -0.76% | 77.91K | Dec 14 | View |
Dec 18, 2023 | Richard William White | CHIEF FINANCIAL OFFICER | -611 | $20.76 | -$12.68K | SELL | -1.20% | 50.354K | Dec 14 | View |
Dec 18, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | -543 | $20.76 | -$11.27K | SELL | -0.26% | 205.131K | Dec 14 | View |
Dec 18, 2023 | Andrew Cheng | PRESIDENT AND CEO | -1.628K | $20.76 | -$33.80K | SELL | -0.29% | 550.911K | Dec 14 | View |
Dec 18, 2023 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -514 | $20.76 | -$10.67K | SELL | -0.28% | 182.672K | Dec 14 | View |
Dec 11, 2023 | Walmsley Graham | — | 100K | $19.83 | $1.98M | BUY | 14.24% | 802.168K | Dec 08 | View |
Dec 11, 2023 | Andrew Cheng | PRESIDENT AND CEO | 91.541K | $13.19 | -$368.39K | SELL-OPTIONS | 19.86% | 552.539K | Dec 07 - Dec 11 | View |
Dec 05, 2023 | Walmsley Graham | — | 100K | $16.95 | $1.69M | BUY | 16.61% | 702.168K | Nov 30 - Dec 01 | View |
Nov 21, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | -30K | $14.68 | -$440.26K | SELL | -14.77% | 173.177K | Nov 17 | View |
Oct 04, 2023 | Andrew Cheng | PRESIDENT AND CEO | 0 | $27.14 | -$1.04M | SELL-OPTIONS | 0.00% | 460.998K | Oct 02 | View |
Oct 04, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | 0 | $36.10 | -$14.70K | SELL-OPTIONS | 0.00% | 203.177K | Oct 02 | View |
Sep 25, 2023 | Andrew Cheng | PRESIDENT AND CEO | -1.682K | $50.34 | -$84.67K | SELL | -0.36% | 460.998K | Sep 13 | View |
Sep 25, 2023 | Richard William White | CHIEF FINANCIAL OFFICER | -632 | $50.34 | -$31.81K | SELL | -3.31% | 18.468K | Sep 13 | View |
Sep 25, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -617 | $27.34 | -$239.62K | SELL | -1.32% | 46.01K | Sep 13 - Sep 21 | View |
Sep 25, 2023 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -531 | $50.34 | -$26.73K | SELL | -0.35% | 150.689K | Sep 13 | View |
Sep 25, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | -562 | $50.34 | -$28.29K | SELL | -0.28% | 203.177K | Sep 13 | View |
Sep 18, 2023 | Andrew Cheng | PRESIDENT AND CEO | 0 | $28.06 | -$1.09M | SELL-OPTIONS | 0.00% | 462.68K | Sep 01 | View |
Aug 30, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | 0 | $28.17 | -$250.65K | SELL-OPTIONS | 0.00% | 46.627K | Aug 28 | View |
Aug 10, 2023 | Walmsley Graham | — | 25K | $42.06 | $1.05M | BUY | 4.33% | 602.168K | Aug 08 | View |
Aug 03, 2023 | Andrew Cheng | PRESIDENT AND CEO | 0 | $24.76 | -$919.87K | SELL-OPTIONS | 0.00% | 447.68K | Aug 01 | View |
Aug 01, 2023 | Walmsley Graham | — | 55K | $42.95 | $2.36M | BUY | 10.53% | 577.168K | Jul 28 - Aug 01 | View |
Jul 06, 2023 | Andrew Cheng | PRESIDENT AND CEO | 0 | $25.62 | -$963.04K | SELL-OPTIONS | 0.00% | 447.68K | Jul 03 | View |
Jun 23, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -33.349K | $51.74 | -$1.73M | SELL | -41.70% | 46.627K | Jun 21 - Jun 23 | View |
Jun 22, 2023 | Richard William White | CHIEF FINANCIAL OFFICER | -3.277K | $31.00 | -$1.02M | SELL | -14.64% | 19.1K | Jun 20 | View |
Jun 21, 2023 | Tomas Heyman | — | 0 | $39.86 | -$770.49K | SELL-OPTIONS | 0.00% | 0 | Jun 16 | View |
Jun 21, 2023 | Jane Henderson | — | 0 | $30.59 | -$1.89M | SELL-OPTIONS | 0.00% | 0 | Jun 16 | View |
Jun 21, 2023 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -38.2K | $27.70 | -$4.26M | SELL | -20.17% | 151.22K | Jun 16 | View |
Jun 15, 2023 | Richard William White | CHIEF FINANCIAL OFFICER | -606 | $55.16 | -$33.43K | SELL | -2.64% | 22.377K | Jun 13 | View |
Jun 15, 2023 | Andrew Cheng | PRESIDENT & CEO | -1.613K | $55.16 | -$88.97K | SELL | -0.39% | 407.68K | Jun 13 | View |
Jun 15, 2023 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -509 | $55.16 | -$28.08K | SELL | -0.27% | 189.42K | Jun 13 | View |
Jun 15, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | -538 | $55.16 | -$29.68K | SELL | -0.26% | 203.739K | Jun 13 | View |
Jun 15, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -591 | $55.16 | -$32.60K | SELL | -0.73% | 79.976K | Jun 13 | View |
Jun 05, 2023 | Andrew Cheng | PRESIDENT AND CEO | 0 | $23.28 | -$1.09M | SELL-OPTIONS | 0.00% | 409.293K | Jun 01 | View |
May 23, 2023 | Walmsley Graham | — | 520K | $29.69 | $15.44M | BUY | 23985.24% | 522.168K | May 19 - Sep 19 | View |
May 03, 2023 | Andrew Cheng | PRESIDENT & CEO | 40K | $22.84 | -$1.09M | SELL-OPTIONS | 10.83% | 409.293K | Apr 18 - May 01 | View |
Apr 05, 2023 | Andrew Cheng | PRESIDENT & CEO | 0 | $19.28 | -$933.20K | SELL-OPTIONS | 0.00% | 369.293K | Apr 03 | View |
Mar 03, 2023 | Andrew Cheng | PRESIDENT & CEO | 0 | $23.63 | -$1.15M | SELL-OPTIONS | 0.00% | 370.999K | Mar 01 | View |
Feb 03, 2023 | Andrew Cheng | PRESIDENT & CEO | 0 | $24.84 | -$1.21M | SELL-OPTIONS | 0.00% | 370.999K | Feb 01 | View |
Jan 18, 2023 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -5K | $50.53 | -$252.65K | SELL | -5.80% | 81.268K | Jan 13 | View |
Jan 05, 2023 | Andrew Cheng | PRESIDENT & CEO | 0 | $25.94 | -$1.27M | SELL-OPTIONS | 0.00% | 370.999K | Jan 03 | View |
Jan 05, 2023 | Jonathan Young | CHIEF OPERATING OFFICER | 0 | $27.63 | -$474.16K | SELL-OPTIONS | 0.00% | 204.911K | Jan 03 | View |
Dec 30, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -12.5K | $39.66 | -$852.35K | SELL | -6.16% | 190.532K | Dec 28 - Dec 29 | View |
Dec 29, 2022 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $28.39 | -$855.14K | SELL-OPTIONS | 0.00% | 23.624K | Dec 27 - Dec 28 | View |
Dec 28, 2022 | Jonathan Young | CHIEF OPERATING OFFICER | 0 | $27.80 | -$544.26K | SELL-OPTIONS | 0.00% | 202.449K | Dec 27 | View |
Dec 13, 2022 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | 14.195K | $43.23 | -$216.14K | GRANT | 19.70% | 86.268K | Dec 09 - Dec 12 | View |
Dec 05, 2022 | Skorpios TrustBlue Horizon Enterprise LtdEzbon International LtdMontrago Trustees Ltd | — | -1.636M | $43.50 | -$71.17M | SELL | -33.33% | 3.271829M | Dec 01 | View |
Dec 02, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $23.34 | -$454.55K | SELL-OPTIONS | 0.00% | 310.148K | Dec 01 | View |
Dec 02, 2022 | Loring Seth Harrison | DIRECTOR | -23.131K | $46.94 | -$1.09M | SELL | -13.51% | 148.063K | Nov 30 | View |
Nov 16, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -7.085K | $45.28 | -$320.81K | SELL | -3.71% | 183.837K | Nov 15 - Nov 16 | View |
Nov 14, 2022 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -5K | $39.42 | -$197.10K | SELL | -6.49% | 72.073K | Nov 10 | View |
Nov 02, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $22.02 | -$428.03K | SELL-OPTIONS | 0.00% | 310.148K | Nov 01 | View |
Nov 01, 2022 | Loring Seth Harrison | DIRECTOR | -44.103K | $40.31 | -$1.78M | SELL | -21.60% | 160.093K | Oct 28 | View |
Oct 27, 2022 | Loring Seth Harrison | DIRECTOR | -285.487K | $42.71 | -$12.19M | SELL | -60.93% | 183.058K | Oct 25 - Oct 27 | View |
Oct 27, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -5.415K | $27.69 | -$591.67K | SELL | -2.76% | 190.922K | Oct 25 - Oct 26 | View |
Oct 27, 2022 | Jonathan Young | CHIEF OPERATING OFFICER | 0 | $25.54 | -$479.44K | SELL-OPTIONS | 0.00% | 183.254K | Oct 25 | View |
Oct 17, 2022 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $23.41 | -$656.22K | SELL-OPTIONS | 0.00% | 4.429K | Oct 13 | View |
Oct 12, 2022 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -5K | $37.99 | -$189.95K | SELL | -6.09% | 77.073K | Oct 10 | View |
Oct 07, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -12.5K | $30.19 | -$673.13K | SELL | -6.29% | 186.337K | Oct 06 | View |
Oct 05, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $16.92 | -$326.13K | SELL-OPTIONS | 0.00% | 310.148K | Oct 03 | View |
Oct 04, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -25K | $24.57 | -$1.14M | SELL | -11.17% | 198.837K | Sep 30 | View |
Sep 15, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $14.02 | -$1.61M | SELL-OPTIONS | 0.00% | 310.148K | Sep 13 | View |
Sep 15, 2022 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -40K | $27.48 | -$1.10M | SELL | -32.77% | 82.073K | Sep 13 | View |
Sep 15, 2022 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $17.02 | -$650.55K | SELL-OPTIONS | 0.00% | 4.429K | Sep 13 | View |
Sep 15, 2022 | Timothy Rolph | CHIEF SCIENTIFIC OFFICER | -22.5K | $29.18 | -$656.55K | SELL | -9.13% | 223.837K | Sep 13 | View |
Mar 02, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $9.10 | -$169.75K | SELL-OPTIONS | 0.00% | 308.996K | Mar 01 | View |
Feb 03, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $9.09 | -$169.45K | SELL-OPTIONS | 0.00% | 308.996K | Feb 01 | View |
Jan 18, 2022 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.52 | -$145.70K | SELL-OPTIONS | 0.00% | 3.277K | Jan 14 | View |
Jan 11, 2022 | Andrew Cheng | PRESIDENT & CEO | 0 | $10.08 | -$189.35K | SELL-OPTIONS | 0.00% | 298.996K | Jan 10 | View |
Dec 23, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.50 | -$1.50K | SELL-OPTIONS | 0.00% | 3.277K | Dec 21 | View |
Dec 20, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.52 | -$48.10K | SELL-OPTIONS | 0.00% | 3.277K | Dec 17 | View |
Dec 03, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $20.18 | -$353.15K | SELL | -6.40% | 255.996K | Dec 02 | View |
Nov 05, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -25K | $24.28 | -$607.12K | SELL | -13.85% | 155.51K | Nov 03 - Nov 04 | View |
Nov 03, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $22.57 | -$394.98K | SELL | -6.01% | 273.496K | Nov 02 | View |
Nov 03, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.62 | -$99.00K | SELL-OPTIONS | 0.00% | 3.277K | Nov 01 | View |
Oct 18, 2021 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -12.5K | $21.59 | -$269.83K | SELL | -9.37% | 120.921K | Oct 15 | View |
Oct 05, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $21.54 | -$376.95K | SELL | -5.67% | 290.996K | Oct 04 | View |
Oct 05, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.53 | -$97.81K | SELL-OPTIONS | 0.00% | 3.277K | Oct 01 | View |
Sep 17, 2021 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -12.5K | $24.69 | -$308.61K | SELL | -8.57% | 133.421K | Sep 15 | View |
Sep 03, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -12.5K | $24.04 | -$300.50K | SELL | -6.48% | 180.51K | Sep 01 | View |
Sep 03, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $15.50 | -$145.43K | SELL-OPTIONS | 0.00% | 3.277K | Sep 01 | View |
Sep 03, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $23.89 | -$418.07K | SELL | -5.37% | 308.496K | Sep 02 | View |
Aug 17, 2021 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -10K | $18.79 | -$187.90K | SELL | -6.41% | 145.921K | Aug 16 | View |
Aug 04, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $14.52 | -$66.71K | SELL-OPTIONS | 0.00% | 3.277K | Aug 02 | View |
Aug 04, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $20.83 | -$364.58K | SELL | -5.09% | 325.996K | Aug 03 | View |
Jul 19, 2021 | Catriona Yale | CHIEF DEVELOPMENT OFFICER | -10K | $20.90 | -$209.04K | SELL | -6.03% | 155.921K | Jul 15 | View |
Jul 08, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $15.76 | -$113.82K | SELL-OPTIONS | 0.00% | 3.277K | Jul 06 | View |
Jul 06, 2021 | Andrew Cheng | PRESIDENT & CEO | -17.5K | $24.78 | -$433.65K | SELL | -4.86% | 342.489K | Jul 02 | View |
Jun 03, 2021 | Kevin Bitterman | DIRECTOR | -17.489K | $26.28 | -$459.61K | SELL | -6.11% | 268.722K | Jun 01 | View |
Jun 02, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.055K | $26.24 | -$80.15K | SELL | -1.63% | 184.01K | Jun 01 | View |
May 04, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.055K | $30.56 | -$93.36K | SELL | -1.61% | 187.065K | May 03 | View |
May 04, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $18.78 | -$98.91K | SELL-OPTIONS | 0.00% | 2.27K | May 03 | View |
Apr 05, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.055K | $28.75 | -$87.83K | SELL | -1.58% | 190.12K | Apr 01 | View |
Apr 05, 2021 | Richard William White | CHIEF FINANCIAL OFFICER | 0 | $17.83 | -$1.08M | SELL-OPTIONS | 0.00% | 2.27K | Apr 01 | View |
Mar 02, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.055K | $30.48 | -$93.11K | SELL | -1.56% | 193.175K | Mar 01 | View |
Feb 02, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.055K | $29.24 | -$89.32K | SELL | -1.53% | 196.23K | Feb 01 | View |
Jan 11, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -2.5K | $14.37 | -$276.59K | SELL | -1.24% | 199.285K | Jan 07 - Jan 08 | View |
Jan 06, 2021 | Jonathan Young | CHIEF OPERATING OFFICER | -3.06K | $25.29 | -$77.40K | SELL | -1.49% | 201.785K | Jan 04 | View |
Oct 14, 2020 | Kevin Bitterman | — | -13K | $28.93 | -$376.09K | SELL | -3.95% | 315.859K | Oct 09 | View |
Jul 14, 2020 | Apple Tree Partners IV LPATP III GP Ltd | — | 415K | $36.00 | $14.94M | PURCHASE | 7.66% | 5.830203M | Jul 10 | View |
Jul 14, 2020 | Loring Seth Harrison | — | 415K | $36.00 | $14.94M | PURCHASE | 7.66% | 5.830203M | Jul 10 | View |
Jul 06, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -116.467K | $34.40 | -$4.01M | SELL | -3.70% | 3.033552M | Jul 01 - Jul 06 | View |
Mar 06, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -45.95K | $23.76 | -$1.09M | SELL | -1.44% | 3.150019M | Mar 04 - Mar 06 | View |
Mar 03, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -21.798K | $22.63 | -$493.31K | SELL | -0.68% | 3.195969M | Feb 28 - Mar 03 | View |
Feb 27, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -5.904K | $22.80 | -$134.64K | SELL | -0.18% | 3.227767M | Feb 25 - Feb 27 | View |
Feb 12, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -10.026K | $27.07 | -$271.40K | SELL | -0.31% | 3.233671M | Feb 10 - Feb 12 | View |
Feb 10, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -6.102K | $27.03 | -$164.95K | SELL | -0.19% | 3.233697M | Feb 06 | View |
Feb 06, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -82.339K | $25.77 | -$2.12M | SELL | -2.48% | 3.239799M | Feb 04 - Feb 05 | View |
Jan 21, 2020 | Versant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLC | — | -59.532K | $20.87 | -$1.24M | SELL | -1.89% | 3.092698M | Jan 16 - Jan 21 | View |
Jan 15, 2020 | Versant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLC | — | -50.837K | $20.04 | -$1.02M | SELL | -1.59% | 3.15223M | Jan 10 - Jan 15 | View |
Jan 14, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -494K | $20.23 | -$9.99M | SELL | -12.95% | 3.322138M | Jan 13 | View |
Jan 10, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -15.677K | $19.86 | -$311.35K | SELL | -0.41% | 3.816138M | Jan 08 | View |
Jan 09, 2020 | Versant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLC | — | -53.057K | $19.99 | -$1.06M | SELL | -1.63% | 3.203067M | Jan 07 - Jan 09 | View |
Jan 08, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -73.221K | $19.86 | -$1.45M | SELL | -1.88% | 3.831815M | Jan 06 - Jan 07 | View |
Jan 06, 2020 | Versant Venture Capital VI LPVersant Ventures VI GP LPVersant Ventures VI GPGP LLC | — | -756.587K | $19.70 | -$1.43M | ACQUISITION OR DISPOSITION | -18.85% | 3.256124M | Jan 02 - Jan 06 | View |
Jan 06, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -35.498K | $19.71 | -$699.72K | SELL | -0.90% | 3.905036M | Jan 02 - Jan 03 | View |
Jan 03, 2020 | venBio Global Strategic Fund II LPvenBio Global Strategic GP II LPvenBio Global Strategic GP II LtdRobert AdelmanCOREY GOODMAN | — | -14.324K | $23.96 | -$343.26K | SELL | -0.36% | 3.940534M | Dec 31 | View |
Dec 31, 2019 | Versant Venture Capital VI LP | 10% OWNER | -389.382K | $24.20 | -$9.42M | SELL | -9.62% | 3.656585M | Dec 27 - Dec 31 | View |
Dec 26, 2019 | Versant Venture Capital VI LP | 10% OWNER | -49.22K | $21.34 | -$1.05M | SELL | -1.20% | 4.045967M | Dec 20 - Dec 26 | View |
Dec 19, 2019 | Versant Venture Capital VI LP | 10% OWNER | -9.671K | $19.56 | -$189.20K | SELL | -0.24% | 4.095187M | Dec 17 - Dec 18 | View |
Browse insider trades on all stocks.